![Larry Alphs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Larry Alphs
Corporate Officer/Principal at
Denovo Biopharma LLC
Net worth: - $ as of 2026-05-30
Profile
Larry Alphs is the founder of International Society For Cns Clinical Trials & Methodology.
Dr. Alphs is Senior Vice President-CNS Development at Denovo Biopharma LLC.
Dr. Alphs was Chief Medical Officer at NetraMark Holdings, Inc. from 2023 to 2026.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-12-22 | 0 ( -.--% ) | - $ | 2026-05-30 |
Larry Alphs active positions
| Companies | Position | Start |
|---|---|---|
Denovo Biopharma LLC
 Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Manufactures personalize and clinical drugs | Corporate Officer/Principal | - |
Former positions of Larry Alphs
| Companies | Position | End |
|---|---|---|
| NETRAMARK HOLDINGS INC. | Chief Tech/Sci/R&D Officer | 2026-05-03 |
International Society For Cns Clinical Trials & Methodology | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Denovo Biopharma LLC
Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Manufactures personalize and clinical drugs | Health Technology |
International Society For Cns Clinical Trials & Methodology | |
NetraMark Holdings, Inc.
 NetraMark Holdings, Inc. Packaged SoftwareTechnology Services Develops app that provides brain health solutions | Technology Services |
- Stock Market
- Insiders
- Larry Alphs
Choose MarketScreener 
